But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response
However, BPC-157 may indirectly support weight management by promoting recovery, supporting physical activity, improving mobility, and potentially contributing to overall wellness
Injectable use carries the usual hazards of non-clinical injection injection-site reactions, and infection or abscess formation when material is not sterile or is handled improperly
They aren't mutually exclusive, of course
I think that the safety profiles are showing that, but again, God forbid you have something growing that you dont know about yet, and you stimulate that, that would stink